Liu, A., Reason, E. H., Sullivan, B. G., Wildman-Tobriner, B., Strickler, J. H., Hsu, D., … Lidsky, M. E. (2025). ASO Visual Abstract: ctDNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion. Ann Surg Oncol. https://doi.org/10.1245/s10434-025-17963-w

Liu, Annie, Ellery H. Reason, Brittany G. Sullivan, Benjamin Wildman-Tobriner, John H. Strickler, David Hsu, Susanna S. Hill, et al. “ASO Visual Abstract: ctDNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.” Ann Surg Oncol, July 22, 2025. https://doi.org/10.1245/s10434-025-17963-w.

Liu A, Reason EH, Sullivan BG, Wildman-Tobriner B, Strickler JH, Hsu D, et al. ASO Visual Abstract: ctDNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion. Ann Surg Oncol. 2025 Jul 22;

Liu, Annie, et al. “ASO Visual Abstract: ctDNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.” Ann Surg Oncol, July 2025. Pubmed, doi:10.1245/s10434-025-17963-w.

Liu A, Reason EH, Sullivan BG, Wildman-Tobriner B, Strickler JH, Hsu D, Hill SS, Thacker JKM, Mantyh CR, Lan B, Nussbaum D, Zani S, Allen PJ, Uronis H, Lidsky ME. ASO Visual Abstract: ctDNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion. Ann Surg Oncol. 2025 Jul 22;